Antiviral therapy for COVID-2019

The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavir-ritonavir, favipiravir, oseltamivir, and umifenovir.  Specific antiviral drugs proven to be effective against SARS-CoV-2 have not been found and approved for the medication of COVID-19. Currently, case detection, infection control, monitoring, prevention, and supportive care are the means focused on the treatment of COVID-19. A large scale research is currently underway to analyze safety and efficacy of antiviral drugs, while trials of the SAR-CoV-2 vaccine are rapidly expanding. This mini review briefly introduces the current antiviral therapy for COVID-19. Key word: Antiviral therapy; Drugs; COVID-19 Citation: Hidayati HB, Octavia E, Srisetyaningrum CT. Antiviral therapy for COVID-2019. Anaesth. pain intensive care 2021;25(3):387–390. DOI: doi.org/10.35975/apic.v25i3.1522 Received: January 8, 2021; Reviewed: March 11, 2021; Accepted: March 11, 2021